Low Cost Alternative (LCA) and Reference Drug Program (RDP) Data Files
Current LCA/RDP data files (effective January 2, 2020)
PharmaCare regularly updates LCA/RDP information in the three data files below. Updates are typically on the first Thursday of every month, but we occasionally make changes mid-month.
See below for how to interpret the data files.
|LCA Master Spreadsheet (XLS)
(January 2, 2020)
|Includes all new and existing generic drugs within the LCA Program with their current reimbursement limits|
|RDP Master Spreadsheet (XLS)
(January 2, 2020)
|Includes all new and existing RDP drugs with their current reimbursement limits|
LCA/RDP Updates Workbook (XLS)
Includes the following four spreadsheets, which provide cumulative information on all new generic drug listings; all new LCA categories; all changes and effective dates for new LCA or RDP reimbursement limits; and any drug de-listings.
- LCA and RDP Data Dictionary (PDF) — detailed explanation of the data fields in the LCA and RDP master spreadsheets
- LCA Pricing Exception List (PDF) — information on pricing exceptions for drugs available in multiple dosage forms and strengths
- List of Manufacturer Codes (PDF) — the codes that appear in the “MAN” field of the LCA/RDP files
If you have questions about the data files, please send a detailed email to PharmaCare.
Occasionally, PharmaCare makes changes to the LCA/RDP between monthly updates. These as-needed changes might include generic drug pricing adjustments or expedited coverage for significant first-entry generics. When this happens, PharmaCare posts updated versions of the above files on the effective date of the change in PharmaCare coverage. Make sure you always have the most recent information by checking this site on the first Thursday of the month and again mid-month.